Newfeed

Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas.Ascentage Pharma to receive an option payment of 100 million USD upon closing and be eligible for an option exercise fee and additional potential milestones o

Driving the Application of XR and Digital Twin for Industrial Metaverse Platform SINGAPORE, June 14, 2024 /PRNewswire/ — Today, DataMesh, an innovator focused on Industrial Metaverse platforms, announced the successful closure of a new funding round, joined by KDDI Open Innovation Fund 3, the

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: